blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP0010347

EP0010347 - Novel substituted omega-aroyl(propionyl or butyryl)-L-prolines, pharmaceutical compositions containing them and processes for their preparation [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  07.09.1984
Database last updated on 11.09.2024
Most recent event   Tooltip07.09.1984No opposition filed within time limitpublished on 07.11.1984 [1984/45]
Applicant(s)For all designated states
AMERICAN CYANAMID COMPANY
Berdan Avenue Wayne
New Jersey 06904 / US
[N/P]
Former [1980/09]For all designated states
AMERICAN CYANAMID COMPANY
Berdan Avenue
Wayne New Jersey 06904 / US
Inventor(s)01 / McEvoy, Francis Joseph
107 Buchanan Street
Pearl River, New York / US
02 / Albright, Jay Donald
5 Clifford Court
Nanuet, New York / US
[1980/09]
Representative(s)Allam, Peter Clerk, et al
Lloyd Wise Commonwealth House, 1-19 New Oxford Street
London WC1A 1LW / GB
[N/P]
Former [1983/45]Allam, Peter Clerk, et al
LLOYD WISE, TREGEAR & CO. Norman House 105-109 Strand
London WC2R 0AE / GB
Former [1980/09]Allam, Peter Clerk
LLOYD WISE, TREGEAR & CO. Norman House 105-109 Strand
London WC2R 0AE / GB
Application number, filing date79301712.021.08.1979
[1980/09]
Priority number, dateUS1978093956405.09.1978         Original published format: US 939564
US1979004473301.06.1979         Original published format: US 44733
[1980/09]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report 
No.:EP0010347
Date:30.04.1980
Language:EN
[1980/09]
Type: B1 Patent specification 
No.:EP0010347
Date:09.11.1983
Language:EN
[1983/45]
Search report(s)(Supplementary) European search report - dispatched on:EP19.02.1980
ClassificationIPC:C07D207/16, C07D403/12, A61K31/40
[1980/09]
CPC:
C07D207/46 (EP); C07C327/00 (EP); C07C59/84 (EP);
C07C59/88 (EP); C07D207/16 (EP)
Designated contracting statesAT,   BE,   CH,   FR,   GB,   IT,   NL,   SE [1980/09]
TitleGerman:Substituierte Omega-Aroyl(propionyl oder butyryl)-L-proline, diese enthaltende pharmazeutische Verbindungen und Verfahren zu ihrer Herstellung[1980/09]
English:Novel substituted omega-aroyl(propionyl or butyryl)-L-prolines, pharmaceutical compositions containing them and processes for their preparation[1980/09]
French:Omega-aroyl(propionyl ou butyryl)-L-prolines substituées, compositions pharmaceutiques les contenant et procédés pour leur préparation[1980/09]
Examination procedure05.07.1980Examination requested  [1980/19]
31.08.1981Despatch of a communication from the examining division (Time limit: M06)
01.03.1982Reply to a communication from the examining division
14.04.1982Despatch of a communication from the examining division (Time limit: M02)
01.06.1982Reply to a communication from the examining division
28.10.1982Despatch of communication of intention to grant (Approval: )
10.01.1983Fee for grant paid
10.01.1983Fee for publishing/printing paid
25.03.1983Communication of intention to grant the patent
Opposition(s)10.08.1984No opposition filed within time limit [1984/45]
Fees paidRenewal fee
21.05.1981Renewal fee patent year 03
07.06.1982Renewal fee patent year 04
11.06.1983Renewal fee patent year 05
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:SearchFR2340933  [ ] (SQUIBB & SONS INC [US]);
 FR2372803  [ ] (SQUIBB & SONS INC [US])
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.